These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 37337289)

  • 1. Update on the pathological roles of prostaglandin E
    Nango H; Tsuruta K; Miyagishi H; Aono Y; Saigusa T; Kosuge Y
    Transl Neurodegener; 2023 Jun; 12(1):32. PubMed ID: 37337289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological role of prostaglandin E2-induced up-regulation of the EP2 receptor in motor neuron-like NSC-34 cells and lumbar motor neurons in ALS model mice.
    Kosuge Y; Miyagishi H; Yoneoka Y; Yoneda K; Nango H; Ishige K; Ito Y
    Neurochem Int; 2018 Oct; 119():132-139. PubMed ID: 28687401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2 production improves safety and efficacy in a mouse model of amyotrophic lateral sclerosis.
    Shin JH; Lee YA; Lee JK; Lee YB; Cho W; Im DS; Lee JH; Yun BS; Springer JE; Gwag BJ
    J Neurochem; 2012 Sep; 122(5):952-61. PubMed ID: 22537108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Cellular Reactive Oxygen Species by Activation of the EP2 Receptor Contributes to Prostaglandin E2-Induced Cytotoxicity in Motor Neuron-Like NSC-34 Cells.
    Kosuge Y; Nango H; Kasai H; Yanagi T; Mawatari T; Nishiyama K; Miyagishi H; Ishige K; Ito Y
    Oxid Med Cell Longev; 2020; 2020():6101838. PubMed ID: 32411331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Motor Neuron Prostaglandin E2 EP3 Receptor Isoform in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Kosuge Y; Miyagishi H; Shinomiya T; Nishiyama K; Suzuki S; Osada N; Ishige K; Okubo M; Kawaguchi M; Ito Y
    Biol Pharm Bull; 2015; 38(12):1964-8. PubMed ID: 26632188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis.
    Liang X; Wang Q; Shi J; Lokteva L; Breyer RM; Montine TJ; Andreasson K
    Ann Neurol; 2008 Sep; 64(3):304-14. PubMed ID: 18825663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Expression of 15-Hydroxyprostaglandin Dehydrogenase in Spinal Astrocytes During Disease Progression in a Model of Amyotrophic Lateral Sclerosis.
    Miyagishi H; Kosuge Y; Takano A; Endo M; Nango H; Yamagata-Murayama S; Hirose D; Kano R; Tanaka Y; Ishige K; Ito Y
    Cell Mol Neurobiol; 2017 Apr; 37(3):445-452. PubMed ID: 27140190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis.
    Bilak M; Wu L; Wang Q; Haughey N; Conant K; St Hillaire C; Andreasson K
    Ann Neurol; 2004 Aug; 56(2):240-8. PubMed ID: 15293276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2-induced cell death is mediated by activation of EP2 receptors in motor neuron-like NSC-34 cells.
    Miyagishi H; Kosuge Y; Yoneoka Y; Ozone M; Endo M; Osada N; Ishige K; Kusama-Eguchi K; Ito Y
    J Pharmacol Sci; 2013; 121(4):347-50. PubMed ID: 23514786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
    Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.
    Ng SK; Higashimori H; Tolman M; Yang Y
    Exp Neurol; 2015 May; 267():115-22. PubMed ID: 25779930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS.
    Drachman DB; Frank K; Dykes-Hoberg M; Teismann P; Almer G; Przedborski S; Rothstein JD
    Ann Neurol; 2002 Dec; 52(6):771-8. PubMed ID: 12447931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis.
    Dodge JC; Jensen EH; Yu J; Sardi SP; Bialas AR; Taksir TV; Bangari DS; Shihabuddin LS
    J Neurosci; 2020 Nov; 40(47):9137-9147. PubMed ID: 33051352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
    MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
    J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Gento-Caro Á; Vilches-Herrando E; Portillo F; González-Forero D; Moreno-López B
    Brain Pathol; 2022 May; 32(3):e13022. PubMed ID: 34585475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.